Paper35923902
Joint Modeling of Incidence of Unfavorable Outcomes and Change in Viral Load Over Time Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospitals of Addis Ababa, Ethiopia.
Zakaria HF and 4 others. HIV AIDS (Auckl), 2022. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Joint Modeling of Incidence of Unfavorable Outcomes and Change in Viral Load Over Time Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospitals of Addis Ababa, Ethiopia. Papers, record 35923902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35923902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Joint Modeling of Incidence of Unfavorable Outcomes and Change in Viral Load Over Time Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospitals of Addis Ababa, Ethiopia.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24312889 | Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients. | Perspect Clin Res | 2013 | https://conductscience.org/library/papers/24312889 | PubMed |
| 2 | 31489067 | Incidence and determinants of mortality among adult HIV infected patients on second-line antiretroviral treatment in Amhara region, Ethiopia: a retrospective follow up study. | Pan Afr Med J | 2019 | https://conductscience.org/library/papers/31489067 | PubMed |
| 3 | 26765104 | Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic. | Glob Health Action | 2016 | https://conductscience.org/library/papers/26765104 | PubMed |
| 4 | 33790656 | Influence of Lost to Follow Up from Antiretroviral Therapy Among Retroviral Infected Patients at Tuberculosis Centers in Public Hospitals of Benishangul-Gumuz, Ethiopia. | HIV AIDS (Auckl) | 2021 | https://conductscience.org/library/papers/33790656 | PubMed |
| 5 | 28594295 | Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar. | Glob Health Action | 2017 | https://conductscience.org/library/papers/28594295 | PubMed |
| 6 | 26572102 | Outcome of patients on second line antiretroviral therapy under programmatic condition in India. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/26572102 | PubMed |
| 7 | 21406048 | HIV treatment adherence, drug resistance, virologic failure: evolving concepts. | Infect Disord Drug Targets | 2011 | https://conductscience.org/library/papers/21406048 | PubMed |
| 8 | 32606835 | Increased Virological Failure and Determinants Among HIV Patients on Highly Active Retroviral Therapy in Adigrat General Hospital, Northern Ethiopia, 2019: Hospital-Based Cross-Sectional Study. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/32606835 | PubMed |
| 9 | 25590271 | Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational database. | J Acquir Immune Defic Syndr | 2015 | https://conductscience.org/library/papers/25590271 | PubMed |
| 10 | 33743748 | Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda. | AIDS Res Ther | 2021 | https://conductscience.org/library/papers/33743748 | PubMed |
| 11 | 28329393 | Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/28329393 | PubMed |
| 12 | 26512561 | Second-Line HIV Therapy Outcomes and Determinants of Mortality at the Largest HIV Referral Center in Southern Vietnam. | Medicine (Baltimore) | 2015 | https://conductscience.org/library/papers/26512561 | PubMed |
| 13 | 32986756 | Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: Multicenter retrospective study. | PLoS One | 2020 | https://conductscience.org/library/papers/32986756 | PubMed |
| 14 | 24028937 | Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. | Glob Health Action | 2013 | https://conductscience.org/library/papers/24028937 | PubMed |
| 15 | 6354290 | Sample-size formula for the proportional-hazards regression model. | Biometrics | 1983 | https://conductscience.org/library/papers/6354290 | PubMed |
| 16 | 31288748 | Incidence and predictors of second-line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study. | BMC Infect Dis | 2019 | https://conductscience.org/library/papers/31288748 | PubMed |
| 17 | 31356613 | Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis. | PLoS One | 2019 | https://conductscience.org/library/papers/31356613 | PubMed |
| 18 | 25472544 | Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/25472544 | PubMed |
| 19 | 27402780 | Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. | J Infect Dis | 2016 | https://conductscience.org/library/papers/27402780 | PubMed |
| 20 | 24498093 | Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study. | PLoS One | 2014 | https://conductscience.org/library/papers/24498093 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 38654969 | Virological Suppression and its Predictors Among HIV/AIDS Patients on Antiretroviral Therapy in Ethiopia: Systematic Review and Meta-analysis. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/38654969 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35923902
GET https://conductscience.org/api/papers/v1/35923902/references?page=2